The American Vascular Association (AVA) and the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), DHHS announce a program that will provide supplemental funding to an individual who receives an NHLBI Mentored Patient-Oriented Research Career Development Award (K23) directed at vascular surgeon scientists in the early stages of their research careers.
Purpose: The AVA is offering this award jointly with the NHLBI as a means to facilitate the research career development of individuals pursuing a career in vascular research. This award will provide financial support over and above that offered by the NHLBI K23 mechanism.
The purpose of the Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research. This mechanism provides support for three to five years of supervised study and research for clinically trained professionals who have the potential to develop into productive, clinical investigators focusing on patient-oriented research. Applicants must justify the need for a period of mentored research experience and provide a convincing case that the proposed period of support and career development plan will substantially enhance their careers as independent investigators in patient-oriented research.
Awards in response to this program announcement will be for a total project period of three, four or five years and are not renewable. Planning, direction, and execution of the proposed career development program and research project will be the responsibility of the applicant and his/her mentor(s). Grants are not transferable from one principal investigator to another.
Eligibility Requirements: The candidate must have a MD degree or equivalent, must have completed postgraduate clinical training in vascular surgery, must identify a mentor with extensive research experience, and must be willing to spend a minimum of 75 percent of full time professional effort conducting research career development and clinical research.
Salary Support: The AVA and the NHLBI will each provide salary and fringe benefits for the K23 recipient. The NHLBI will award up to $75,000 up to five years and the AVA will provide $50,000 up to three years. No indirect costs will be paid to the institution.
Awards in response to this program announcement will use the K23 mechanism. Applications should conform to the guidelines published for the NIH Mentored Patient-Oriented Research Career Development Award (K23) available at the following address: http://grants.nih.gov/training/careerdevelopmentawards.htm. Applications must be submitted electronically using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide.
Application dates are available at: http://grants1.nih.gov/grants/funding/submissionschedule.htm.
To be considered for the AVA supplemental funding, you must submit your application to NHLBI and AVA at the same time. If you are selected to receive the supplemental award, AVA will contribute $50,000 per year in addition to whatever is awarded by the NHLBI under the K23 provisions.
To identify the application as a response to this program announcement:
Review Considerations: Applications will be reviewed for completeness by the Center for Scientific Review and for responsiveness to this program announcement by the AVA and by the NHLBI. Applications that are complete and responsive to the program announcement will be evaluated for scientific and technical merit by an appropriate peer review group convened at the NHLBI in accordance with the standard NIH peer review procedures. Representatives of the AVA Research and Education Committee will participate in the NIH peer review group. As part of the initial merit review, all applications will receive a written critique and undergo a process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed, assigned a priority score, and receive a second level review by the appropriate advisory council or board. The applications will also receive a secondary review by the AVA Research and Education Committee.
Award Process: Following your submission to both NHLBI and AVA, continue to inform the AVA Research and Education Committee of activity related to your K23 application, including resubmission and funding. In spring of each year, the AVA Research and Education Committee will review applications that have received NHLBI/NIH funding. If you are selected to receive the AVA supplemental award, the award will be presented at the annual meeting of the Society for Vascular Surgery in June.
For questions regarding eligibility requirements and the K23 application process:
Jane D. Scott, ScD, MSN, FAHA
Director, Office of Research Training and Career Development
Division of Cardiovascular Disease
National Heart, Blood, and Lung Institute, NIH
Rockledge II, 8138
6701 Rockledge Drive
Bethesda, MD 20892
Phone: 301-435-0535
Fax: 301-480-7404
scottj2@nhlbi.nih.gov
For questions regarding the AVA:
Phone: 800-258-7188
Fax: 312-334-2320
Email: ava@vascularsociety.org
Past Award Winners
| 2008 |
|
Christopher D. Owens, MD |
| 2007 |
|
Vikram S. Kashyap, MD |
| 2006 |
| Matthew S. Edwards, MD Assistant Professor of Surgery Wake Forest University Baptist Medical Center Winston-Salem, North Carolina Project Title: Embolic Protection During Renal Artery Stenting |
| 2005 |
| Gregory J. Landry, MD Assistant Professor of Surgery Oregon Health & Science University Portland, Oregon Project Title: Functional Outcome of Critical Limb Ischemia Mentor: Dr. Lloyd Taylor, Oregon Health & Science University |